Literature DB >> 24388657

Tracheostomy versus mandibular distraction osteogenesis in infants with Robin sequence: a comparative cost analysis.

Emma C Paes1, James J Fouché2, Marvick S M Muradin3, Lucienne Speleman4, Moshe Kon2, Corstiaan C Breugem2.   

Abstract

Many treatments have been described for infants with Robin sequence and severe respiratory distress, but there have not been many comparative studies of outcome and cost-effectiveness. The aim of this study was to compare the cost and complications of two common interventions - mandibular distraction osteogenesis and tracheostomy. Nine patients with isolated Robin sequence (mandibular distraction osteogenesis, n=5, and tracheostomy, n=4) were included in the analyses. Predetermined costs and complications were obtained retrospectively from medical records and by questionnaires to the parents over a 12-month period. Overall direct costs (admission to hospital, diagnostics, surgery, and homecare) were 3 times higher for tracheostomy (€105.523 compared with €33.482, p=0.02). Overall indirect costs (absence from work) were almost 5 times higher (€2.543 compared with €543, p=0.02). There was a threefold increase in overall total cost/patient (both direct and indirect) for tracheostomy (€108.057 compared with 34.016, p=0.02) and 4 times more complications were encountered. This study shows that mandibular distraction osteogenesis in infants diagnosed with Robin sequence costs significantly less and results in fewer complications than tracheostomy, and this contributes to our current knowledge about the ideal approach for infants with Robin sequence and might provide a basis for institutional protocols in the future.
Copyright © 2013 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  (Pierre) Robin sequence; Cost analyses; Mandibular distraction osteogenesis; Tracheostomy; Treatment

Mesh:

Year:  2013        PMID: 24388657     DOI: 10.1016/j.bjoms.2013.11.017

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  7 in total

Review 1.  Surgical Management and Outcomes of Pierre Robin Sequence: A Comparison of Mandibular Distraction Osteogenesis and Tongue-Lip Adhesion.

Authors:  Rosaline S Zhang; Ian C Hoppe; Jesse A Taylor; Scott P Bartlett
Journal:  Plast Reconstr Surg       Date:  2018-08       Impact factor: 4.730

Review 2.  Craniofacial disorders associated with airway obstruction in the neonate.

Authors:  Christopher M Cielo; Fernando M Montalva; Jesse A Taylor
Journal:  Semin Fetal Neonatal Med       Date:  2016-03-17       Impact factor: 3.926

Review 3.  Craniofacial syndromes and sleep-related breathing disorders.

Authors:  Hui-Leng Tan; Leila Kheirandish-Gozal; François Abel; David Gozal
Journal:  Sleep Med Rev       Date:  2015-06-06       Impact factor: 11.609

4.  A pragmatic approach to infants with Robin sequence: a retrospective cohort study and presence of a treatment algorithm.

Authors:  Emma C Paes; Daan P F van Nunen; Lucienne Speleman; Marvick S M Muradin; Bram Smarius; Moshe Kon; Aebele B Mink van der Molen; Aebele B Mink van der Molen; Titia L E M Niers; Esther S Veldhoen; Corstiaan C Breugem
Journal:  Clin Oral Investig       Date:  2015-02-15       Impact factor: 3.573

5.  Mandibular Distraction Osteogenesis: Upper Airway Management in Pierre Robin Sequence.

Authors:  Patrick A Newbury; Nicholas S Adams; John A Girotto
Journal:  Eplasty       Date:  2015-09-04

6.  Piezosurgery: A new and safe technique for distraction osteogenesis in Pierre Robin sequence review of the literature and case report.

Authors:  Manlio Galié; Valentina Candotto; Giovanni Elia; Luigi C Clauser
Journal:  Int J Surg Case Rep       Date:  2014-12-05

7.  Infant Mandibular Distraction for Upper Airway Obstruction: A Clinical Audit.

Authors:  Ashim N Adhikari; Andrew A C Heggie; Jocelyn M Shand; Patrishia Bordbar; Anastasia Pellicano; Nicky Kilpatrick
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-07-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.